MDXH — MDxHealth SA Income Statement
0.000.00%
- $76.41m
- $103.01m
- $70.19m
- 56
- 47
- 45
- 47
Annual income statement for MDxHealth SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.8 | 18.5 | 22.2 | 37.1 | 70.2 |
Cost of Revenue | |||||
Gross Profit | -0.144 | 7.94 | 10.4 | 19.2 | 43.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 55 | 45.6 | 49.1 | 75 | 97.5 |
Operating Profit | -43.2 | -27.1 | -26.8 | -37.9 | -27.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -43.7 | -28.7 | -29 | -44 | -43.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -43.1 | -28.7 | -29 | -44 | -43.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -43.1 | -28.7 | -29 | -44 | -43.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -43.1 | -28.7 | -29 | -44 | -43.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -6.23 | -3.41 | -2.38 | -2.77 | -1.66 |
Dividends per Share |